Research Pipeline
A BALANCED AND TARGETED PIPELINE
Our research expands in scope each year, primarily focused on respiratory, neonatal, and special care therapies.
AIR
Respiratory therapies are the hub of our research and development activities. Our potential products address needs for conditions including asthma, chronic obstructive pulmonary disease and more. Chiesi USA’s pipeline researches new molecular entities to uncover progress on anti-inflammatory, bronchodilator, and antifibrotic molecules.
CARE
Our special healthcare therapies and product portfolio for conditions related to neonatology and the treatment of acute conditions. We continue to improve our existing programs as we seek to expand our therapeutic reach.
RARE
Chiesi Global Rare Diseases is focused on research and development of treatments for those affected by rare and ultra-rare diseases. We aim to realize more fulfilling lives for those who need innovative approaches to treatment.
